Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. Halting the state’s opioid crisis with the help of medical cannabis can be done, and here’s how.

Programs 52

Programs Chronic Pain Treatment Conditions 52

MGC Pharma

FEBRUARY 22, 2018

While at home in Australia, the Medical Cannabis industry is still working hard to gather more evidence-based research to substantiate treatment assertions, relevant studies are already occurring overseas. of respondents who received Medical Cannabis treatment reported improvement in their condition and significant reductions to pain levels.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

Veriheal

APRIL 21, 2022

Australian Natural Therapeutics Group (ANTG) secured the first local cannabis farm which is 100% legal and now the group is bringing medical grade to the pharmacies of New Zealand. ANTG received the approval of the Ministry of Health to stock the shelves with cannabis tea. The Approved Cannabis Product in New Zealand.

Chronic Pain 95

Chronic Pain Pharmaceutical Medicine Patients 95

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

LifeCannMD

NOVEMBER 24, 2023

Cannabis doctors charge different consultation fees which are not covered by insurance at this time. Medical marijuana may be recommended for conditions such as chronic pain, epilepsy, multiple sclerosis, Crohn’s disease, cancer, and other qualifying conditions.

Marijuana 52

Marijuana Chronic Pain Conditions Strains 52

Canna Care Docs

DECEMBER 11, 2018

For many who were young in the 1960s and 70s, cannabis was something seen at parties, possibly experimented with, but for the most part set aside. But what explains this turnaround, and what do seniors need to be aware of when it comes to medical cannabis? Here, too, cannabis has been shown to have a distinct effect.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

MMJ Recs

FEBRUARY 3, 2024

This guide aims to navigate the intricate web of cannabis legislation in Philadelphia, Pennsylvania, exploring key aspects such as medical marijuana laws, cannabis regulations, qualifying conditions, patient eligibility, and the overall impact on the local cannabis industry.

Legislation 52

Legislation Law Marijuana Dispensary 52

MedicalJane

OCTOBER 28, 2022

It is true that the COVID-19 pandemic has harmed many cannabis companies’ bottom lines; however, it hasn’t impacted the medical marijuana market in the same way it has the recreational or adult-use market. Pharmaceuticals. according to a report published by Fortune Business Insights earlier in the year.

Chronic Pain 86

Chronic Pain Marijuana Medicine Pharmaceutical 86

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

The Cannigma

JUNE 25, 2022

Recreational cannabis is not legal in Poland and the plant is still legally considered a narcotic. Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Poland and cannabis. Possible penalties for cannabis.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug. What is Marinol?

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Veriheal

AUGUST 13, 2020

In talking about cannabis and its uses, a lot of attention is always paid to THC, the most well known cannabinoid in the cannabis plant. THC is primarily responsible for the psychoactive effects users feel, and it also helps to combat nausea, increase appetite, encourage sleep, and relieve chronic pain.

Cannabinoids 98

Cannabinoids Chronic Pain Sleep Pharmaceutical 98

Veriheal

AUGUST 9, 2023

Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. Presently, CBD is inarguably the most acceptable compound in cannabis. Some have even explored it for its aphrodisiac potential.

CBD 93

CBD Cannabinoids THC Extraction 93

MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. These may include chronic pain, nausea and vomiting related to chemotherapy, muscle spasms, seizures, and mental health disorders.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

Cannabis Law Report

APRIL 1, 2022

CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years. Its admission represents a ‘huge milestone for Celadon’, according to the new entity’s CEO James Short, but also for the UK cannabis industry at large. Business Cann. Admission .

Chronic Pain 52

Chronic Pain Pharmaceutical Sativa Business 52

Cannabis Law Report

NOVEMBER 23, 2021

A development application for a medical cannabis cultivation facility in New South Wales’ Bathurst region has been lodged with Bathurst Regional Council. It’s expected the facility will produce around 8 tonnes of medical cannabis per annum – whether that is total biomass or finished product isn’t clear. Hemp Gazette reports.

Chronic Pain 52

Chronic Pain Epilepsy Environment Pharmaceutical 52

Cannabis Law Report

JUNE 7, 2019

Where else would Britain’s biggest cannabis farm be but in ‘The Garden of England’? The farm is run by GW Pharmaceuticals, where around two million cannabis plants have been produced since its opening in 1998. But not everyone suffering from these conditions will be able to access it.

Chronic Pain 40

Chronic Pain Epilepsy Legalization Pharmaceutical 40

The Cannigma

AUGUST 25, 2021

Cannabis use is decriminalized in Italy and those who take part typically do not face legal consequences. That said, the possession or sale of cannabis is illegal and can be punished by severe penalties. A conviction for selling cannabis can result in a six year prison sentence. Qualifying conditions for medical cannabis.

Legalization 52

Legalization Chronic Pain Decriminalization Conditions 52

Veriheal

NOVEMBER 10, 2020

France has been accused of falling behind in the cannabis race and has thus been urged to take action on medical cannabis before they’re left behind. In response, the French government announced that they will be carrying out a medical cannabis experiment which will involve distributing free medical cannabis. .

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76

Weedistry

DECEMBER 29, 2018

Most of the wave of incoming leaders after our recent midterm elections, at the state and federal level, support expanding access to medical marijuana. The taboo of medical cannabis as a valid form of treatment is lifting. The post Gordon: Medical cannabis, two years later appeared first on Weedistry.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. RYAH Group Inc. How to Use the Data.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

FEBRUARY 15, 2019

A landmark moment for the UK’s cannabis industry occurred this week when the first bulk shipments of marijuana were imported into Britain since legislation changed in November. In case you were wondering, Marks, at his peak, claimed to have been smuggling 30 tons of the drug in each consignment.).

History 56

History Legalization Chronic Pain Pharmaceutical 56

MMJ Recs

JANUARY 22, 2024

In recent years, the landscape of medicinal cannabis has undergone a significant transformation, with an increasing focus on alternative consumption methods. As a non-psychoactive compound derived from the cannabis plant, CBD interacts with the body’s endocannabinoid system to promote balance and alleviate various health concerns.

Edibles 52

Edibles Marijuana Chronic Pain THC 52

Veriheal

JUNE 20, 2022

Do you have a homie who’s been arrested over cannabis? “Free the Homies” is a joint art project between Washington-based cannabis company Solstice and Seattle-based artist Teddy “Stat” Phillips that aims to spread awareness about unjust cannabis-related incarceration in the U.S. Are you the homie?

Chronic Pain 95

Chronic Pain Advocacy Pharmaceutical Legalization 95

Cannabis Law Report

JANUARY 19, 2022

Frankfurt : C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”) a distributor of medical and CBD wellness cannabis products in Germany announces that its wholly-owned subsidiary, AMP Alternative Medical Products GmbH (“AMP”) and Little Green Pharma Ltd. HAMBURG, Germany and PERTH, Australia , Jan. ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

Veriheal

MAY 17, 2021

There are 36 states in the United States that have chosen the legalization of medical cannabis for residents of their states. Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. District Attorneys Believe Medical Cannabis is a Lie.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Cannabis Law Report

JANUARY 4, 2022

DUBLIN–(BUSINESS WIRE)–The “Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Product Type (Marijuana, Hemp), By Application (Medical Use, Industrial Use), And Segment Forecasts, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering. Illicit Cannabis Trade.

Legalization 52

Legalization Supply Chain Chronic Pain Sleep 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

MAY 28, 2019

PUBLISHER: CANNABIS LAW REPORT. Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Other common health problems include tinnitus, hearing loss, and lower-back pain. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Cannabis Law Report

JANUARY 15, 2020

million Series A funding round in 2019, Cannaray has announced the fulfilment of its first UK patient prescription as the company continues to grow, becoming one of UK’s largest Medical Cannabis and CBD company. . Cannaray today announces the fulfilment of its first Medical Cannabis prescription in the UK. Following a £7.8

CBD 64

CBD Epilepsy Chronic Pain Treatment 64

Cannabis Law Report

NOVEMBER 14, 2019

Barriers confronting patients trying to access medicinal cannabis in Australia will be scrutinised in a Parliamentary inquiry into how the drug is regulated. The Greens said the medicinal cannabis system is “broken” and in urgent need of reform as their push for an inquiry into access to the drug won support in the Senate on Thursday.

Access 49

Access Medicine Chronic Pain Patients 49

Cannabis Law Report

DECEMBER 14, 2019

F ) (OTCPK: AGFAF ), a growth oriented and diversified international cannabis company, is pleased to announce that the Company’s United Kingdom (the “UK”) subsidiary, Farmako Limited has completed its UK Home Office inspection for the purpose of obtaining a Controlled Drug License. million active cannabis users in the UK.

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59